Madrid, Spain

Jose R Gomez

This inventor holds 3 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jose R Gomez. Retrieved from https://idiyas.com/inventor/jose-r-gomez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jose R Gomez

Introduction

Jose R Gomez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of antifungal compounds, holding a total of 3 patents. His work has been instrumental in advancing the development of effective antifungal agents.

Latest Patents

Among his latest patents, Gomez has developed antifungal sordaridin derivatives and carbocyclic compounds. One of his notable inventions includes a compound of formula ##STR1## wherein Z is a tetrahydro-pyrano group selected from ##STR2##, which exhibits antifungal activity in combination with other antifungal agents. This innovation showcases his commitment to addressing critical health challenges.

Career Highlights

Gomez is currently associated with Glaxo Wellcome Inc., a leading pharmaceutical company. His role there has allowed him to focus on research and development in the field of antifungal treatments. His expertise and innovative mindset have contributed to the company's advancements in this area.

Collaborations

Throughout his career, Gomez has collaborated with esteemed colleagues such as Silvestre Garcia-Ochoa Dorado and Domingo Gargallo Viola. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Jose R Gomez's contributions to the field of antifungal compounds are noteworthy and reflect his dedication to innovation. His patents and collaborations continue to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…